FDA approved drugs
SILICO MODELING AND DOCKING OF Cch1 PROTEIN OF CANDIDA GLABRATA WITH FDA APPROVED DRUGS: A DRUG REPURPOSING APPROACH
6
Identification of fda approved drugs with activity for hiv- a computational drug repositioning approach
12
Potential inhibitors of SARS-CoV-2 Main protease (M pro ) identified from the library of FDA approved drugs using molecular docking studies
24
Exploring anti malarial potential of FDA approved drugs: an in silico approach
15
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
14
Identification of FDA approved drugs with activity against Lassa virus- A computational drug repositioning approach.
12
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
11
Screening of FDA Approved Drugs Against COVID-19 Main Protease: Coronavirus Disease
8
Possible FDA-approved drugs to treat Ebola virus infection
11
In Vitro Analysis of Nine MicroRNAs in CD8+ T Cells of Asthmatic Patients and the Effects of Two FDA-approved Drugs
11
NEW FDA APPROVED DRUGS FOR THE TREATMENT FOR ATOPIC DERMATITIS
8
Novel anti glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
13
Repurposing of FDA approved drugs as COVID-19 therapeutics: Safety concerns and contraindications of drugs in clinical trials
28
Off-Label or out of Bounds? Prescriber and Marketer Liability for Unapproved Uses of FDA-Approved Drugs
31
Evaluation of a library of FDA approved drugs for their ability to potentiate antibiotics against multidrug resistant Gram negative pathogens
11
Simeprevir, potential candidate to repurpose for coronavirus infection: Virtual screening and molecular docking study
12
An antiviral Drug combinational studies against Lassa virus- A computational drug repositioning approach
12
Pharmaceuticals: The Battle for Control in the 21st Century
47
Current pharmacotherapeutic approaches to treat diabetic neuropathy
10
“Drug-Likeness” versus “Natural Product-Likeness”
16